Income Statement
EXOZYMES INC.
EXOZ
Performance Overview
Click any row in the table to add it to this chart
in millions USD
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY |
|---|---|---|
|
Revenue
|
- | - |
|
Cost of Revenue
|
- | - |
|
Gross Profit
|
- | - |
|
Operating Expenses
|
9.72 | 5.93 |
|
Research & Development
|
3.71 | 1.87 |
|
Selling, General & Administrative
|
6.01 | 4.06 |
|
Other Operating Expenses
|
- | - |
|
Operating Income
|
-9.72 | -5.93 |
|
Non-Operating Income
|
-0.45 | -0.07 |
|
Interest Income
|
- | - |
|
Interest Expense
|
- | - |
|
Other Non-Op Income / Expense
|
0.09 | -0.01 |
|
Income Before Tax
|
-9.26 | -5.86 |
|
Income Tax Expense
|
-0.11 | 0.00 |
|
Non-Controlling Interest
|
- | - |
|
Net Income
|
-9.16 | -5.86 |
Supplemental
Per share data, derived & other items — not part of the income statement
in millions USD unless noted
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY |
|---|---|---|
|
Depreciation & Amortization
|
- | - |
|
EBITDA
|
-9.72 | -5.93 |
|
Earnings Per Share (Basic)
|
-1.09 | -0.89 |
|
Diluted EPS
|
-1.09 | -0.89 |
|
Weighted Average Shares
|
8.38 | 6.56 |
|
Diluted Weighted Avg Shares
|
8.38 | 6.56 |
|
Comprehensive Income
|
- | - |